Success Metrics

Clinical Success Rate

100.0%

Based on 3 completed trials

Completion Rate

100%(3/3)

Active Trials

2(33%)

Results Posted

0%(0 trials)

Phase Distribution

Ph not_applicable

50%

Ph phase_2

17%

Ph phase_3

17%

Ph early_phase_1

17%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution6 total trials

Early Phase 1First-in-human

1(16.7%)

Phase 2Efficacy & side effects

1(16.7%)

Phase 3Large-scale testing

1(16.7%)

N/ANon-phased studies

3(50.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(2)

Completed(3)

Other(1)

Detailed Status

Completed3

Active, not recruiting1

Recruiting1

unknown1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 3

Trials by Phase

Early Phase 11 (16.7%)

Phase 21 (16.7%)

Phase 31 (16.7%)

N/A3 (50.0%)

Trials by Status

completed350%

active_not_recruiting117%

recruiting117%

unknown117%

Recent Activity

2 active trials

Showing 5 of 6

recruitingnot_applicable

Regenarative Treatment of Periocular Wrinkles With PDRN

NCT07280637

completednot_applicable

Multicenter, Prospective Study to Determine the Performance and Safety of the New M-HA30 Architect Device on the Quality of the Skin: HEBE8 Study

NCT07007351

active_not_recruitingphase_3

Clinical Trials (6)

Showing 6 of 6 trials

NCT07280637Not Applicable

Regenarative Treatment of Periocular Wrinkles With PDRN

Recruiting

NCT07007351Not Applicable

Multicenter, Prospective Study to Determine the Performance and Safety of the New M-HA30 Architect Device on the Quality of the Skin: HEBE8 Study

Completed

NCT06293755Phase 3

Microneedle Patch With Botulinum Toxin in Management of Enlarged Facial Pores

Active Not Recruiting

NCT05251831Early Phase 1

Comparative Study Efficacy and Safety of of Activated Versus Non-Activated PRP

Completed

NCT04519346Not Applicable

Mesotherapy Versus Systemic Therapyin Treatment of Migraine Headache

Completed

NCT01684956Phase 2

Pharmacokinetic Comparison of Intradermal Versus Sub-cutaneous Insulin and Glucagon Delivery in Type 1 Diabetes

Unknown

All 6 trials loaded

Drug Details

Intervention Type: PROCEDURE
Total Trials: 6